I think I was primed for a knee-jerk reaction because when Alphafold's results were announced back in Dec. 2020, with expressions of what a boon it would be for researchers around the globe, I anticipated there would be a timeline announced for exposing a tool or for the open-sourcing. (The Github repo has only just been released about 6 days ago ...)
With all the work on SARS-CoV-2's 'interactome', as well as human proteins & enzymes involved in pharmacology of antiviral drugs under development / repurposing , it's easy to imagine that drug developers would have liked to exercise Alphafold as soon as it was announced. (I myself have wanted a structure for human enzyme OATP1A2 that wasn't available on the PDB for such a drug pharmacology study - quite glad it is available at hand now.. .:) ).
Anyway I'm sure good arguments will be made about the need to really 'get it right' before releasing, or internal deliberations on how much to open up vs charging for it.
But 7 months lead time during a pandemic is a long time...
In all cases thanks again for this innovation's availability now. :)